Anti-cancer drug containing snake venom extract
By using a multi-step purification process to extract high-purity snake venom extract and combining it with traditional Chinese medicine components, the problem of poor anti-cancer effects in existing cancer treatments has been solved, achieving stronger anti-cancer effects and enhanced immune function.
Patent Information
- Application Number
- CN202411449043.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-17
- Publication Date
- 2024-11-29
AI Technical Summary
Existing cancer treatments such as surgery, chemotherapy, radiotherapy, and traditional Chinese medicine are unable to effectively kill cancer cells, and snake venom extracts have insufficient active ingredients, resulting in minimal anti-cancer effects.
High-purity snake venom extract is extracted using a multi-step purification process and combined with various traditional Chinese medicine components such as Ganoderma lucidum, licorice, and ginger to improve overall immune function and enhance anti-cancer effects.
It enhances the anti-cancer effect of snake venom extract, preserves the activity of snake venom enzymes through multi-step purification, strengthens the inhibitory effect on cancer cells, and improves overall immunity through the synergistic effect of traditional Chinese medicine components.
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of anticancer drugs, in particular to an anticancer drug containing a snake venom extract. Background Art
[0002] Cancer, or malignant tumor, is a major disease that endangers human life. Existing treatment methods include (1) surgical treatment, which is based on the removal of tumor tissue through surgical means. It is suitable for the treatment of solid tumors. Its advantages are that it can directly remove cancer lesions, effectively remove special tumor sites that are insensitive to radiation or difficult for drugs to reach, and provide doctors with key information for pathological analysis. However, it cannot ensure the complete removal of all microlesions, which may lead to postoperative recurrence. Patients need to tolerate the pressure of surgery and anesthesia. There are risks of damaging surrounding normal tissues, infection, bleeding, etc. It is ineffective for cancer that has already metastasized. (2) Chemotherapy, which is based on the use of chemical drugs to fight cancer cells. It is a systemic treatment method that mainly targets rapidly dividing cells. Cancer cells proliferate faster than normal cells, so they become the main target of chemotherapy. (3) Radiotherapy, which is based on the use of high-energy ionizing radiation (such as X-rays, gamma rays, etc.) to destroy tumor cells. The radiation kills cancer cells, causing them to stop proliferating until they die. Then the body's own clearance mechanism will gradually decompose and eliminate these damaged cancer cells. (4) Traditional Chinese Medicine Treatment: The snake venom products currently used internationally are all single extracts that cannot kill cancer cells. In addition, the snake venom extracts do not contain enough active ingredients and have little anti-cancer effect.
[0003] Based on this, it is of great practical significance to provide an anticancer drug containing snake venom extract which can be used in combination with a traditional Chinese medicine component to effectively kill cancer cells. Summary of the invention
[0004] The purpose of the present invention is to provide an anticancer drug containing snake venom extract. The anticancer drug of the present invention contains purified snake venom extract, which can maximize the anticancer effect of the anticancer drug. The anticancer drug and traditional Chinese medicine components act synergistically to improve the immune function as a whole, thereby improving the anticancer effect of the anticancer drug.
[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0006] The present invention provides an anticancer drug containing a snake venom extract, the anticancer drug comprising: 0.1 to 0.5 parts of the snake venom extract and 50 to 60 parts of a traditional Chinese medicine component;
[0007] Wherein, the preparation method of the snake venom extract is:
[0008] Collect fresh Agkistrodon acutus snake venom;
[0009] The Agkistrodon acutus venom is mixed with a buffer solution to dissolve the mixture, and then centrifuged to obtain a supernatant;
[0010] The supernatant was first purified using an anion exchange column to collect the active components:
[0011] The active components are subjected to a second purification using molecular sieves to obtain a snake venom extract.
[0012] Furthermore, the Chinese medicinal components include: 8-12 parts of Ganoderma lucidum, 8-12 parts of licorice, 8-10 parts of ginger, 8-10 parts of Atractylodes macrocephala, 8-10 parts of Herba Cynomorii, 10-15 parts of Lobelia, 8-10 parts of Leonurus japonicus, 8-12 parts of Salvia miltiorrhiza, 15-20 parts of Rhubarb, 4-8 parts of Taraxacum officinale, 1 part of Allicin and 1 part of Ascorbic acid.
[0013] Furthermore, the method for collecting fresh Agkistrodon acutus venom is a live collection method.
[0014] Furthermore, the buffer solution is tris(hydroxymethylaminomethane) hydrochloric acid buffer solution; the pH value of the buffer solution is 7.0, and the concentration is 0.005-0.007M.
[0015] Furthermore, the ratio of the Agkistrodon acutus venom to the buffer solution is 1-2:3-5.
[0016] Furthermore, the centrifugal speed is 8000-10000 rpm, and the time is 30-40 min.
[0017] Furthermore, the eluent for the first purification is a sodium citrate solution; the pH value of the sodium citrate solution is 6.4-6.5, and the concentration is 0.05M.
[0018] Furthermore, the molecular sieve is a gel filtration column.
[0019] Furthermore, the eluent used in the second purification is a sodium bicarbonate solution, and the concentration of the sodium bicarbonate solution is 0.05M.
[0020] The present invention also provides the use of the anticancer drug containing the snake venom extract described in the above technical solution in the treatment of breast cancer and cervical cancer.
[0021] Compared with the prior art, the technical solution of the present invention has the following beneficial effects:
[0022] (1) The present invention uses the Agkistrodon acutus venom extract to inhibit cancer cells, thereby alleviating the pain of cancer patients; in addition, the present invention uses the snake venom extract in combination with a Chinese medicine component to maintain the activity of the enzyme in the snake venom, promote the effectiveness of the snake venom, and enhance the anti-cancer effect of the snake venom extract;
[0023] (2) The present invention performs multi-step purification on the venom to obtain a highly pure anti-cancer active ingredient, namely, a snake venom extract. The highly pure snake venom extract is mixed with a traditional Chinese medicine component to further obtain an anti-cancer drug with a better anti-cancer effect;
[0024] (3) The present invention uses a mixture of multiple Chinese medicine components to improve the overall immune ability, and then synergize with the snake venom extract to improve the anti-cancer effect. DETAILED DESCRIPTION
[0025] The present invention provides an anticancer drug containing a snake venom extract, the anticancer drug comprising: 0.1 to 0.5 parts of the snake venom extract and 50 to 60 parts of a traditional Chinese medicine component;
[0026] Wherein, the preparation method of the snake venom extract is:
[0027] Collect fresh Agkistrodon acutus snake venom;
[0028] The Agkistrodon acutus venom is mixed with a buffer solution to dissolve the mixture, and then centrifuged to obtain a supernatant;
[0029] The supernatant was first purified using an anion exchange column to collect the active components:
[0030] The active components are subjected to a second purification using molecular sieves to obtain a snake venom extract.
[0031] In the present invention, the anticancer drug preferably comprises 0.1 to 0.3 parts of snake venom extract and 50 to 55 parts of traditional Chinese medicine components;
[0032] In the present invention, the Chinese medicinal components preferably include: 8-12 parts of Ganoderma lucidum, 8-12 parts of licorice, 8-10 parts of ginger, 8-10 parts of Atractylodes macrocephala, 8-10 parts of Herba Cynoglossi, 10-15 parts of Lobelia, 8-10 parts of Leonurus japonicus, 8-12 parts of Salvia miltiorrhiza, 15-20 parts of Rhubarb, 4-8 parts of Taraxacum officinale, 1 part of allicin and 1 part of ascorbic acid; further preferably include 8-10 parts of Ganoderma lucidum, 8-10 parts of licorice, 8-9 parts of ginger, 8-9 parts of Atractylodes macrocephala, 8-9 parts of Herba Cynoglossi, 10-12 parts of Lobelia, 8-9 parts of Leonurus japonicus, 8-10 parts of Salvia miltiorrhiza, 15-17 parts of Rhubarb, 4-6 parts of Taraxacum officinale, 1 part of allicin and 1 part of ascorbic acid.
[0033] The invention adopts a mixture of multiple Chinese medicine components to improve the immune ability as a whole, and then synergizes with the snake venom extract to improve the anti-cancer effect.
[0034] The present invention uses the Agkistrodon acutus venom extract to inhibit cancer cells, thereby alleviating the pain of cancer patients; in addition, the present invention uses the snake venom extract in combination with a traditional Chinese medicine component to maintain the activity of enzymes in the snake venom, promote the effectiveness of the snake venom, and enhance the anti-cancer effect of the snake venom extract.
[0035] In the present invention, the method for collecting fresh Agkistrodon acutus venom is preferably live collection.
[0036] The live collection method of the present invention is preferably to place the Agkistrodon acutus naturally on a workbench, hold the snake's neck with one hand, and put the glass dish into the snake's mouth with the other hand, so that venom flows out after the snake bites, and fresh Agkistrodon acutus venom is obtained.
[0037] In the present invention, the buffer is preferably a tris-hydrochloric acid buffer; the pH value of the buffer is preferably 7.0; the concentration is preferably 0.005 to 0.007M, and more preferably 0.005 to 0.006M.
[0038] In the present invention, the ratio of the Agkistrodon acutus venom to the buffer solution is preferably 1-2:3-5, and more preferably 1-2:3-4.
[0039] In the present invention, the centrifugal speed is preferably 8000-10000 rpm, more preferably 8000-9000 rpm, and the time is preferably 30-40 min, more preferably 30-35 min.
[0040] In the present invention, the eluent for the first purification is preferably a sodium citrate solution; the pH value of the sodium citrate solution is preferably 6.4-6.5, and the concentration is preferably 0.05M.
[0041] In the present invention, the molecular sieve is preferably a gel filtration column.
[0042] In the present invention, the eluent used in the second purification is preferably a sodium bicarbonate solution, and the concentration of the sodium bicarbonate solution is preferably 0.05M.
[0043] The present invention performs multi-step purification on snake venom to obtain a high-purity anti-cancer effective component, namely a snake venom extract. The high-purity snake venom extract is mixed with a traditional Chinese medicine component to further obtain an anti-cancer drug with a better anti-cancer effect.
[0044] The present invention also provides the use of the anticancer drug containing the snake venom extract described in the above technical solution in the treatment of breast cancer and cervical cancer.
[0045] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0046] Example 1
[0047] (1) 8 parts of Ganoderma lucidum, 8 parts of liquorice, 8 parts of ginger, 8 parts of Atractylodes macrocephala, 8 parts of Herba Polygoni Multiflori, 10 parts of Lobelia, 8 parts of Leonurus japonicus, 8 parts of Salvia miltiorrhiza, 15 parts of Rhubarb, 4 parts of Taraxacum officinale, 1 part of Allicin and 1 part of ascorbic acid are mixed, and then crushed to obtain a mixed Chinese medicine powder; then water is added and boiled for 1.5 hours, filtered, and the obtained filtrate is boiled again for 2 hours, and finally filtered to obtain a liquid Chinese medicine component, which is stored for later use;
[0048] (2) Place the Agkistrodon acutus naturally on a workbench, hold the snake's neck with one hand, and put a glass dish into the snake's mouth with the other hand. When the snake bites, venom will flow out. The collected Agkistrodon acutus venom is mixed with 0.005 M Tris-HCl buffer solution with a pH value of 7.0 at a ratio of 1:4 to dissolve;
[0049] (3) After dissolving the Agkistrodon acutus venom, centrifuge at 8000 rpm for 30 min to obtain a supernatant, purify the supernatant using an anion exchange column, and elute with a sodium citrate solution with a pH of 6.4 and a concentration of 0.05 M to obtain an active component;
[0050] (4) purifying the active component again using a gel filtration column and eluting with a 0.05 M sodium bicarbonate solution to obtain a snake venom extract;
[0051] (5) 0.1 parts of the snake venom extract are mixed with 50 parts of the traditional Chinese medicine components to obtain the anticancer drug containing the snake venom extract.
[0052] Example 2
[0053] (1) 10 parts of Ganoderma lucidum, 10 parts of liquorice, 9 parts of ginger, 9 parts of Atractylodes macrocephala, 9 parts of Herba Polygoni Multiflori, 12 parts of Lobelia chinensis, 9 parts of Leonurus japonicus, 10 parts of Salvia miltiorrhiza, 17 parts of Rhubarb, 6 parts of Taraxacum officinale, 1 part of Allicin and 1 part of ascorbic acid are mixed, and then crushed to obtain a mixed Chinese medicine powder; then water is added and boiled for 1.5 hours, filtered, and the obtained filtrate is boiled again for 2 hours, and finally filtered to obtain a liquid Chinese medicine component, which is stored for later use;
[0054] (2) Place the Agkistrodon acutus naturally on a workbench, hold the snake's neck with one hand, and put a glass dish into the snake's mouth with the other hand. When the snake bites, venom will flow out. The collected Agkistrodon acutus venom is mixed with 0.005M Tris-HCl buffer solution with a pH value of 7.0 at a ratio of 1:5 to dissolve;
[0055] (3) After dissolving the Agkistrodon acutus venom, centrifuge at 9000 rpm for 35 min to obtain a supernatant, purify the obtained supernatant using an anion exchange column, and elute with a sodium citrate solution with a pH of 6.5 and a concentration of 0.05 M to obtain an active component;
[0056] (4) purifying the active component again using a gel filtration column and eluting with a 0.05 M sodium bicarbonate solution to obtain a snake venom extract;
[0057] (5) 0.3 parts of the snake venom extract are mixed with 55 parts of the traditional Chinese medicine components to obtain the anticancer drug containing the snake venom extract.
[0058] Example 3
[0059] (1) 12 parts of Ganoderma lucidum, 12 parts of liquorice, 10 parts of ginger, 10 parts of Atractylodes macrocephala, 10 parts of Herba Polygoni Multiflori, 15 parts of Lobelia chinensis, 10 parts of Leonurus japonicus, 12 parts of Salvia miltiorrhiza, 20 parts of Rhubarb, 8 parts of Taraxacum officinale, 1 part of Allicin and 1 part of ascorbic acid are mixed, and then crushed to obtain a mixed Chinese medicine powder; then water is added and boiled for 1.5 hours, filtered, and the obtained filtrate is boiled again for 2 hours, and finally filtered to obtain a liquid Chinese medicine component, which is stored for later use;
[0060] (2) Place the Agkistrodon acutus naturally on a workbench, hold the snake's neck with one hand, and put a glass dish into the snake's mouth with the other hand. When the snake bites, venom will flow out. The collected Agkistrodon acutus venom is mixed with 0.005 M Tris-HCl buffer solution with a pH value of 7.0 in a ratio of 1:2 to dissolve;
[0061] (3) After dissolving the Agkistrodon acutus venom, centrifuge at a speed of 10,000 rpm for 40 minutes to obtain a supernatant, purify the obtained supernatant using an anion exchange column, and elute with a sodium citrate solution with a pH of 6.4 and a concentration of 0.05 M to obtain an active component;
[0062] (4) purifying the active component again using a gel filtration column and eluting with a 0.05 M sodium bicarbonate solution to obtain a snake venom extract;
[0063] (5) 0.5 parts of the snake venom extract are mixed with 60 parts of the traditional Chinese medicine components to obtain the anticancer drug containing the snake venom extract.
[0064] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. An anticancer drug containing snake venom extract, characterized in that: The anticancer drug comprises: 0.1-0.5 parts of snake venom extract and 50-60 parts of traditional Chinese medicine components; Wherein, the preparation method of the snake venom extract is: Collect fresh Agkistrodon acutus snake venom; The Agkistrodon acutus venom is mixed with a buffer solution to dissolve the mixture, and then centrifuged to obtain a supernatant; The supernatant was first purified using an anion exchange column to collect the active components: The active components are subjected to a second purification using molecular sieves to obtain a snake venom extract.
2. The anticancer drug containing snake venom extract according to claim 1, characterized in that: The Chinese medicinal components include: 8-12 parts of ganoderma lucidum, 8-12 parts of liquorice, 8-10 parts of ginger, 8-10 parts of atractylodes macrocephala, 8-10 parts of rhubarb, 10-15 parts of lobelia, 8-10 parts of motherwort, 8-12 parts of salvia miltiorrhiza, 15-20 parts of rhubarb, 4-8 parts of dandelion, 1 part of allicin and 1 part of ascorbic acid.
3. The anticancer drug containing snake venom extract according to claim 1, characterized in that: The method for collecting fresh Agkistrodon acutus venom is a live collection method.
4. The anticancer drug containing snake venom extract according to claim 1, characterized in that: The buffer solution is tris(hydroxymethylaminomethane) hydrochloric acid buffer solution; the pH value of the buffer solution is 7.0, and the concentration is 0.005-0.007M.
5. The anticancer drug containing snake venom extract according to claim 1, characterized in that: The ratio of the Agkistrodon acutus venom to the buffer solution is 1-2:3-5.
6. The anticancer drug containing snake venom extract according to claim 1, characterized in that: The centrifugal speed is 8000-10000 rpm, and the time is 30-40 min.
7. The anticancer drug containing snake venom extract according to claim 1, characterized in that: The eluent for the first purification is a sodium citrate solution; the pH value of the sodium citrate solution is 6.4-6.5, and the concentration is 0.05M.
8. The anticancer drug containing snake venom extract according to claim 1, characterized in that: The molecular sieve is a gel filtration column.
9. The anticancer drug containing snake venom extract according to claim 1, characterized in that: The eluent used in the second purification is a sodium bicarbonate solution, and the concentration of the sodium bicarbonate solution is 0.05M.
10. Use of the anticancer drug containing snake venom extract according to any one of claims 1 to 9 in the treatment of breast cancer and cervical cancer.
Citation Information
Patent Citations
Haemocoagulase agkistrodon and separation method thereof
CN102757948A
Method for preparing anti-cancer traditional Chinese medicine containing Mingri leaf
CN1408417A
Snake poison capsule for treating lung cancer and its preparation method
CN1426800A
The mixture of Agki-strodon venom and Chinese medical herb extract and its application
CN1943777A
